In the wake of President-elect Donald Trump’s decision to appoint ex-Democratic Rep. Tulsi Gabbard as his Director of ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...
Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's ...
Why this news will impact the lives of people affected by Alzheimer's disease: The first disease-modifying therapies for ...
Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...
Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...